In vivo experimental mouse model to test CD19CAR T cells generated with different methods.

Fåne, Anne; Myhre, Marit Renée; Inderberg, Else Marit; Wälchli, Sebastien

Fåne, Anne; Myhre, Marit Renée; Inderberg, Else Marit; Wälchli, Sebastien.

Afiliação

Fåne A; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.
Myhre MR; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.
Inderberg EM; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway.
Wälchli S; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway. Electronic address: sebastien.walchli@rr-research.no.

Methods Cell Biol ; 167: 149-161, 2022.

Article em En | MEDLINE | ID: mdl-35152992

Assuntos

Neoplasias; Linfócitos T; Animais; Linhagem Celular; Linhagem Celular Tumoral; Imunoterapia Adotiva/métodos; Camundongos; Neoplasias/metabolismo; Receptores de Antígenos de Linfócitos T/metabolismo; Linfócitos T/metabolismo

Palavras-chave

CAR; Chimeric antigen receptor; Immunotherapy; In vivo study; T cell; Xenograft model

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Neoplasias Tipo de estudo: Guideline Limite: Animals Idioma: En Revista: Methods Cell Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Noruega

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google